David Colcher
Impact in
- Radiology, Nuclear Medicine and Imaging top 0.05%
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 0.5%
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 114
- Radiopharmaceutical Chemistry and Applications 101
- Oncology 75
- HER2/EGFR in Cancer Research 23
- CAR-T cell therapy research 14
- Co-authors
- Jeffrey Schlom (85 shared papers)Patricia Horan Hand (18 shared papers)Marianna Nuti (8 shared papers)Surinder K. Batra (17 shared papers)Andrew Raubitschek (38 shared papers)Gabriela Pavlínková (16 shared papers)Barbara J.M. Booth (16 shared papers)Otto A. Gansow (14 shared papers)
- Journals
- International Journal of Cancer (13 papers)Cancer Biotherapy and Radiopharmaceuticals (9 papers)Journal of Nuclear Medicine (8 papers)Bioconjugate Chemistry (8 papers)Blood (7 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
David Colcher
209 papers receiving 9.9k citations
David Colcher's Hit Papers
Peers
Comparison fields: 5 of 116
- Radiology, Nuclear Medicine and Imaging 6.8k
- Oncology 3.0k
- Immunology 1.9k
- Molecular Biology 3.9k
- Biotechnology 454
Countries citing papers authored by David Colcher
This map shows the geographic impact of David Colcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Colcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Colcher more than expected).
Fields of papers citing papers by David Colcher
This network shows the impact of papers produced by David Colcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Colcher. The network helps show where David Colcher may publish in the future.
Co-authors
The 25 scholars most cited alongside David Colcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Hit paper breakdown → | 1981 | 495 |
| 2 | A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells Hit paper breakdown → | 2011 | 488 |
| 3 | Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. | 1986 | 382 |
| 4 | 1982 | 291 | |
| 5 | 1990 | 265 | |
| 6 | 1986 | 259 | |
| 7 | Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. | 1988 | 190 |
| 8 | 2006 | 189 | |
| 9 | 2002 | 183 | |
| 10 | Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. | 1983 | 179 |
| 11 | Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. | 2000 | 176 |
| 12 | 2005 | 171 | |
| 13 | Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens. | 1983 | 170 |
| 14 | 1987 | 156 | |
| 15 | Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma. | 1987 | 150 |
| 16 | 2013 | 130 | |
| 17 | Pharmacokinetics and biodistribution of genetically-engineered antibodies. | 1998 | 125 |
| 18 | Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies. | 1988 | 122 |
| 19 | Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein. | 1985 | 116 |
| 20 | Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients. | 1987 | 115 |
About David Colcher
David Colcher is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, having authored 216 papers that have together received 10.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (114 papers), Radiopharmaceutical Chemistry and Applications (101 papers), Glycosylation and Glycoproteins Research (38 papers), HER2/EGFR in Cancer Research (23 papers), Immunotherapy and Immune Responses (20 papers), CAR-T cell therapy research (14 papers), Cancer Research and Treatments (14 papers) and Virus-based gene therapy research (13 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (6.8k citations), Oncology (3.0k citations), Immunology (1.9k citations), Molecular Biology (3.9k citations) and Biotechnology (454 citations). David Colcher has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Jeffrey Schlom, Patricia Horan Hand, Marianna Nuti, Surinder K. Batra, Andrew Raubitschek, Gabriela Pavlínková, Barbara J.M. Booth, Otto A. Gansow, Mario Roselli and Diane E. Milenic. Their work appears in journals such as International Journal of Cancer, Cancer Biotherapy and Radiopharmaceuticals, Journal of Nuclear Medicine, Bioconjugate Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.